Fundraising FoxBasilard BioTech
4 known investors
Find your way into Basilard BioTech
Sign up to find every way you can get introduced to Basilard BioTech
- Your email: who you already know at Basilard BioTech, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Basilard BioTech team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Basilard BioTech develops Celletto, a nanomechanical (mechanoporation) gene delivery platform that inserts genes directly into the nucleus of cells without viral vectors, aimed at cell and gene therapy (CGT) developers and manufacturers. The technology targets the gene-delivery bottleneck in engineering cell-based therapies, offering an alternative to viral, chemical, and physical delivery methods.
Investors · 4
How we know: GENERAL INCEPTION's portfolio page · Not right? Tell us
How we know: funding news · basilardbiotech.com · the VCSheet dataset · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountpre-seedMar 2020
Vertical Venture Partners (VVP)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Basilard BioTech do?
- Basilard BioTech develops Celletto, a nanomechanical (mechanoporation) gene delivery platform that inserts genes directly into the nucleus of cells without viral vectors, aimed at cell and gene therapy (CGT) developers and manufacturers. The technology targets the gene-delivery bottleneck in engineering cell-based therapies, offering an alternative to viral, chemical, and physical delivery methods.
- Who are Basilard BioTech's investors?
- Basilard BioTech's investors include Band of Angels, GENERAL INCEPTION, Paladin Capital Group, Vertical Venture Partners.